Literature DB >> 11414262

Antihypertensive medication use in Hispanic adults: a comparison with black adults and white adults.

J J Sudano1, D W Baker.   

Abstract

BACKGROUND: Variations in awareness, treatment, and control of hypertension among different racial/ethnic groups have been widely reported. It is unclear whether these differences are explained fully by differences in socioeconomic status, insurance coverage, health status, and health behaviors, or whether these differences indicate that racial/ethnic subgroups have unique barriers to hypertension control.
OBJECTIVES: Determine whether there are significant differences between racial/ethnic groups in medication use for hypertension after adjusting for potentially confounding variables. RESEARCH
DESIGN: Cross-sectional analysis of the 1992 Health and Retirement Study.
SUBJECTS: 2450 non-Hispanic white, 939 non-Hispanic black, and 345 Hispanic participants, ages 51 to 61, reporting a history of hypertension. MEASURES: Self-reported current antihypertensive medication use. We used logistic regression to adjust for demographics, socioeconomic status, health status, insurance, and health risk behaviors.
RESULTS: 63.6% of white adults, 72.6% of black adults, and 52.5% of Hispanic adults reported current medication use to control hypertension (P <0.001 across all three groups). In stratified analysis, the lower rate of use for Hispanic adults was consistent regardless of gender, insurance coverage, or health status. After controlling for all variables, the adjusted prevalence for Hispanic adults was 50.8% and 73.3% for black adults.
CONCLUSIONS: The differences in antihypertensive medication use between white adults, black adults, and Hispanic adults, particularly the markedly lower rates among Hispanic adults, are not explained by differences in demographics, socioeconomic status, health insurance coverage, health status, or health risk behaviors. Alternative explanations for these results and areas for future research and intervention are explored.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414262     DOI: 10.1097/00005650-200106000-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  13 in total

1.  The relation of hypertension to changes in ADL/IADL limitations of Mexican american older adults.

Authors:  Grace I L Caskie; Maryann C Sutton; Jennifer A Margrett
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-01-28       Impact factor: 4.077

2.  Association Between Health Literacy and Medication Adherence Among Hispanics with Hypertension.

Authors:  Maichou Lor; Theresa A Koleck; Suzanne Bakken; Sunmoo Yoon; Ann-Margaret Dunn Navarra
Journal:  J Racial Ethn Health Disparities       Date:  2019-01-03

Review 3.  Medication nonadherence: an unrecognized cardiovascular risk factor.

Authors:  Mark A Munger; Benjamin W Van Tassell; Joanne LaFleur
Journal:  MedGenMed       Date:  2007-09-19

4.  The Spanish translation and adaptation of the Uniform Data Set of the National Institute on Aging Alzheimer's Disease Centers.

Authors:  Amarilis Acevedo; Kristin R Krueger; Ellen Navarro; Freddy Ortiz; Jennifer J Manly; Margarita M Padilla-Vélez; Sandra Weintraub; Oscar L López; Dan Mungas
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

5.  Gender and ethnic differences in subarachnoid hemorrhage.

Authors:  S V Eden; W J Meurer; B N Sánchez; L D Lisabeth; M A Smith; D L Brown; L B Morgenstern
Journal:  Neurology       Date:  2008-06-11       Impact factor: 9.910

6.  A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial.

Authors:  Antoinette Schoenthaler; Franzenith de la Calle; Maria Pitaro; Audrey Lum; William Chaplin; Jazmin Mogavero; Milagros C Rosal
Journal:  J Gen Intern Med       Date:  2019-10-17       Impact factor: 5.128

7.  Depression and glycemic control in Hispanic primary care patients with diabetes.

Authors:  Raz Gross; Mark Olfson; Marc J Gameroff; Olveen Carasquillo; Steven Shea; Adriana Feder; Rafael Lantigua; Milton Fuentes; Myrna M Weissman
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

8.  Determinants of racial/ethnic differences in blood pressure management among hypertensive patients.

Authors:  LeRoi S Hicks; Shimon Shaykevich; David W Bates; John Z Ayanian
Journal:  BMC Cardiovasc Disord       Date:  2005-06-22       Impact factor: 2.298

9.  Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).

Authors:  Henry R Black; Fernando Aguirre P; Melanie Wright; Thomas Alessi; Fabio Baschiera
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-07       Impact factor: 3.738

10.  Factors associated with study protocol adherence and bio banking participation in reproductive medicine clinical trials and their relationship to live birth.

Authors:  Lawrence Engmann; Fangbai Sun; Richard S Legro; Michael P Diamond; Heping Zhang; Nanette Santoro
Journal:  Hum Reprod       Date:  2020-12-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.